Rongtai health(603579)2024-04-15 11:38Financial Performance Forecast - The company expects a net profit attributable to shareholders for Q1 2024 to be between 59.25 million and 64.58 million yuan, an increase of 21.75 million to 27.08 million yuan compared to the same period last year, representing a year-on-year increase of 58.00% to 72.22%[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses is expected to be between 57.55 million and 62.89 million yuan, an increase of 31.69 million to 37.02 million yuan compared to the same period last year, representing a year-on-year increase of 122.50% to 143.11%[5]. - The net profit for the same period last year was 37.50 million yuan, and the net profit after deducting non-recurring gains and losses was 25.87 million yuan[6]. Factors Influencing Performance - The company attributes the performance increase to the recovery of consumer demand and the optimization of product structure, as well as the expansion of domestic and international market share[7]. - The company emphasizes that there are no significant uncertainties affecting the accuracy of this performance forecast[8]. Reporting and Disclosure - The forecast data is preliminary and the final financial data will be disclosed in the official Q1 2024 report[9].